John Nicols, CEO & President of Codexis, Inc. will be moderating a session titled “Leveraging Synthetic Biology for Biopharma Innovation” on May 9th, 2018 from 3:30-4:00 pm. He will also be giving Welcome and Opening remarks for the conference.
Boston CEO is a networking forum for industry CEOs and decision makers in the life sciences. Attendees gain insights from presentations and panels featuring CEOs from several of the world’s leading biopharmaceutical companies. Industry leaders in venture capital and private equity also participate. For more information, please visit https://bbbiotechconference.com/conference-agenda.php?id=70.